Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1105 studies found for:    "Glioblastoma"
Show Display Options
Rank Status Study
1 Not yet recruiting INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)
Condition: Glioblastoma
Interventions: Drug: Temozolomide;   Drug: Neratinib;   Drug: CC-115;   Drug: Abemaciclib
2 Completed Comparison of Different Methods to Test MGMT Status in Glioblastoma Patients
Condition: Glioblastoma
Interventions: Drug: Temozolomide;   Radiation: Radiation Therapy
3 Completed Epothilone in Recurrent Glioblastoma Patients
Condition: Glioblastoma
Intervention: Drug: ZK 219477
4 Terminated Clinical Study on the Safety and Tolerability of Macitentan in Combination With Dose-dense Temozolomide in Patients With Recurrent Glioblastoma
Condition: Glioblastoma
Interventions: Drug: Phase 1 Dose Escalation;   Drug: Phase 1b;   Drug: Ancillary Study
5 Completed Clinical Study on Macitentan, RT and TMZ Concurrent Therapy Followed by Maintenance Macitentan and TMZ in Newly Diagnosed Glioblastoma
Condition: Glioblastoma
Intervention: Drug: Macitentan in combination with RT and TMZ
6 Completed APG101 in Glioblastoma
Condition: Glioblastoma Multiforme
Interventions: Drug: APG101;   Procedure: Blood drawing
7 Completed Clinical Trial to Assess the Efficacy and Safety of 'INNOCELL Immuncell-LC' With Temozolomide in Newly Diagnosed Glioblastoma of Korea
Condition: Glioblastoma
Intervention: Drug: Activated T lymphocyte(Immuncell-LC)
8 Recruiting Impact of the Platelet Level in Patients Treated for Glioblastoma With Temozolomid
Condition: Glioblastoma
Intervention: Other: Platelet level determination
9 Terminated Peptide-based Glioma Vaccine IMA950 in Patients With Glioblastoma
Condition: Glioblastoma
Interventions: Drug: Cyclophosphamide;   Biological: IMA950 plus GM-CSF;   Biological: IMA950;   Drug: Imiquimod
10 Completed A Study of MEDI-575 in Subjects With Recurrent Glioblastoma Multiforme
Condition: Glioblastoma Multiforme
Intervention: Drug: MEDI-575
11 Terminated Effect of Radiation Therapy Plus Temozolomide Combined With Cilengitide or Cetuximab on the 1-year Overall Survival of Patients With Newly Diagnosed MGMT-promoter Unmethylated Glioblastoma
Condition: Glioblastoma
Interventions: Drug: Cetuximab;   Drug: Cilengitide EMD 121974
12 Recruiting FMISO PET Study of Glioblastoma
Condition: Recurrent Glioblastoma
Interventions: Device: FMISO PET;   Device: MRI;   Drug: Bevacizumab;   Drug: CCNU
13 Recruiting Autologuos Lymphoid Effector Cells Specific Against Tumour (ALECSAT) as Add on to Standard of Care in Patients With Glioblastoma
Condition: Glioblastoma
Interventions: Biological: ALECSAT;   Radiation: radiotherapy;   Drug: Temozolomide
14 Completed Randomized Phase 2 With CpG-ODN in Malignant Glioblastoma
Condition: Glioblastoma
Intervention: Drug: CpG-ODN
15 Completed Neo-adjuvant Treatment With Temozolomide and Bevacizumab Previous to Temozolomide Plus Radiation Plus Bevacizumab Therapy in Unresectable Glioblastoma
Condition: Glioblastomas
Interventions: Drug: Temozolomide;   Drug: Bevacizumab;   Radiation: Standard radiation therapy
16 Completed A Pilot Trial Testing the Feasibility of Molecular Profiling in Recurrent/Progressive Glioblastoma
Condition: Adult Glioblastoma
Intervention: Other: specialized tumor board recommendation
17 Recruiting Efficacy, Safety and CNS Exposure of G-202 (Mipsagargin) in Patients With Recurrent or Progressive Glioblastoma
Condition: Glioblastoma Multiforme
Intervention: Drug: G-202
18 Completed
Has Results
A Study of ICT-107 Immunotherapy in Glioblastoma Multiforme (GBM)
Condition: Glioblastoma Multiforme
Interventions: Biological: ICT-107;   Biological: Placebo DC
19 Unknown  Carbon Ion Radiotherapy for Primary Glioblastoma
Condition: Primary Glioblastoma
Interventions: Radiation: Carbon Ion Radiotherapy;   Radiation: Proton Radiotherapy
20 Terminated
Has Results
Study of Everolimus (RAD001) in Patients With Recurrent Glioblastoma Multiforme (GBM)
Condition: Glioblastoma Multiforme
Interventions: Drug: Everolimus;   Procedure: Surgery

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.